Composition of molecular cardiolipin species correlates with proliferation of lymphocytes

Experimental Biology and Medicine

Volumn 237, Issue 4, 2012, Pages 372-379

  Schild, Lorenz ^a   Lendeckel, Uwe ^b   Gardemann, Andreas ^a   Wiswedel, Ingrid ^a   Schmidt, Christian Andreas ^b   Wolke, Carmen ^b   Walther, Reinhard ^b   Grabarczyk, Piotr ^b   Busemann, Christoph ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Cardiolipin; Lymphocyte; Molecular species of cardiolipin; Proliferation

Indexed keywords

CARDIOLIPIN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; OXIDATION;

APOPTOSIS; CARDIOLIPINS; CELL PROLIFERATION; HUMANS; LYMPHOCYTE COUNT; LYMPHOCYTES; OXIDATION-REDUCTION;

EID: 84860595795     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011311     Document Type: Article

References (45)

1. Lecocq F, Ballou CE. On the structure of cardiolipin. Biochemistry 1964;3:976-80
2. De Kroon AI, Dolis D, Mayer A, Lill R, de Kruijff B. Phospholipid composition of highly purified mitochondrial outer membranes of rat liver and Neurospora crassa. Is cardiolipin present in the mitochondrial outer membrane? Biochim Biophys Acta 1997;1325:108-16
3. Kiebish MA, Han X, Cheng H, Chuang JH, Seyfried TN. Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. J Lipid Res 2008;49:2545-56
4. Li J, Romestaing C, Han X, Li Y, Hao X, Wu Y, Sun C, Liu X, Jefferson LS, Xiong J, Lanoue KF, Chang Z, Lynch CJ, Wng H, Shi Y. Cardiolipin remodeling by ALCAT1 links oxidative stress and mitochondrial dysfunction to obesity. Cell Metab 2010;12:154-64
5. van Gestel RA, Rifken J, Surinova S, O'Flaherty M, Heck AJR, Killian JA, de Kroon AEPM, Slifper M. The influence of the acyl-chain composition of cardiolipin on the stability of mitochondrial complexes; an unexpected effect of cardiolipin in α-ketoglutarate dehydrogenase and prohibitin complexes. J Proteom 2010;73:806-14
6. Schlame M, Ren M. Barth syndrome, a human disorder of cardiolipin metabolism. FEBS Lett 2006;560:5450-5
7. Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN. The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer. Nutr Metab (Lond) 2007;4:5
8. Han X, Yang J, Yang K, Zhao Z, Abendschein DR, Gross RW. Alterations in myocardial cardiolipin content and composition occur at the very earliest stage of diabetes: a shot gun lipodomics study. Biochemistry 2007;46:6417-28
9. Pope S, Lan JM, Heales SJ. Oxidative stress and mitochondrial dysfunction in neurodegeneration; cardiolipin a critical target? Biochim Biophys Acta 2008;1777:794-9
10. Canuto RA, Biocca ME, Muzio G, Dianzani MU. Fatty acid composition of phospolipids in mitochondria and microsomes during diethynitrosamine carcinogenesis in rat liver. Cell Biochem Fund 1989;7:11-9
11. Hartz JW, Morion RI, Walte MM, Morris HP. Correlation of fatty acyl composition of mitochondrial and microsomal phospolipid with growth rate of rat hepatomas. Lab Invest 1982;46:73-8
12. Hoch FL. Cardiolipins and biomembrane function. Biochim Biophys Acta 1992;1113:71-133
13. Hoch FL. Cardiolipins and mitochondrial proton-selective leakage. J Bioenerg Biomembr 1998;30:511-32
14. Jahnke VE, Sabido O, Defour A, Castells J, Lefai E, Roussel D, Freyssenet D. Evidence for mitochondrial respiratory deficiency in rat rhabdomyosarcoma cells. PLoS One 2010;5:e8637
15. Kaltoft K, Bisballe S, Rasmussen HF, Thestrup-Pedersen K, Thomsen K, Sterry WA. Continuous T-cell line from a patient with Sezary syndrome. Arch Dermatol Res 1987;279:293-8
16. Schlame M, Shanske S, Doty S, König T, Sculco T, Dimauro S, Blanck T. Microanalysis of cardiolipin in small biopsies including skeletal muscle from patients with mitochondrial disease. J Lipid Res 1990;40: 1585-92
17. Valianpour F, Wanders RJA, Barth PG, Overmars H, van Gennip AH. Quantitative and compositional study of cardiolipin in platelets by electrospray ionization mass spectrometry: application for the identification of Barth syndrome patients. Clin Chem 2002;48:1390-7
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-75
19. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 2005;1:223-32
20. Kiebish MA, Han X, Cheng H, Seyfried TN. In vitro growth environment produces lipidomic and electron transport chain abnormalities in mitochondria from non-tumorigenic astrocytes and brain tumours. ASN Neurol 2009;1:e00011
21. Struchkov VA, Strazhevskaya NB, Zhdanov RI. DNA-bound lipids of normal and tumor cells: retrospective and outlooks for functional genomics. Bioelectrochemistry 2002;58:23-30
22. Zhdanov RI, Struchkov VA, Dyabina O, Strazhevskaya NB. Chromatin-bound cardiolipin: the phospholipid of proliferation. Cytobios 2001;106:55-61
23. Struchkov VA, Strazhevskaya NB. Structural and functional aspects of nuclear lipids in normal and tumor cells. Biochemistry (Mosc.) 2000;65:525-45
24. Haines TA. A new look at cardiolipin. Biochim Biophys Acta 2009;1788:1997-2002
25. Hatch GM. Cardiolipin: biosynthesis, remodeling and trafficking in the heart and mammalian cells (Review). Int J Mol Med 1998;1:33-41
26. Schlame M, Rüstow B. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria. Biochem J 1990;272:589-95
27. 2 vwith unsaturated fatty acids. J Biol Chem 1983;4759-61
28. Kapralov AA, Yanamala N, Tyurina YY, Castro L, Arias AS, Vladimirov YA, Maeda A, Weitz AA, Peterson J, Mylnikov D, Demicheli V, Tortora V, Klein-Seetharaman J, Radi R, Kagan VE. Topography of tyrosine residues and their involvement in peroxidation of polyunsaturated cardiolipin in cytochrome c/cardiolipin peroxidase complexes. Biochim Biophys Acta 2011;808:2147-55
29. Schug ZT, Gottlieb E. Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta 2009;1788: 2022-31
30. Petrosillo G, Ruggiero FM, Pistolese M, Paraies G. Reactive oxygen species generated from the mitochondrial electron transport chain induce cytochrome c dissociation from beef-heart submitochondrial particles via cardiolipin peroxidation. Possible role in the apoptosis. FEBS Lett 2001;509:435-8
31. Kagan VE, Bayir HA, Belikova NA, Kapralov O, Tyurina YY, Tyurin VA, Jiang J, Stoyanovsky DA, Wipf P, Kochanek PM, Greenberger JS, Pitt B, Shvedova AA, Borisenko G. Cytochrome c/cardiolipin relations in mitochondria: a kiss of death. Free Radic Biol Med 2009;46: 1439-53
32. Scorrano L. Caspase-8 goes cardiolipin: a new platform to provide mitochondria with microdomains of apoptotic signals? J Cell Biol 2008;183:579-81
33. Kim J, Minkler PE, Salomon RG, Anderson VE, Hoppel CL. Cardiolipin: characterization of distinct oxidized molecular species. J Lipid Res 2011;52:125-35
34. Rigoulet M, Yoboue ED, Devin A. Mitochondrial ROS generation and its regulation: mechanisms involved in H(2)O(2) signaling. Antioxid Redox Signal 2011;14:459-68
35. Pearce EL. Metabolism in T-cell activation and differentiation. Curr Opin Immunol 2010;22:314-20
36. Warburg O. On the origin of cancer cells. Science 1956;123:309-14
37. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005;24:6314-22
38. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, Shih R, Parks JS, Edwards PA, Jamieson BD, Tontonoz P. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008;134:97-111
39. Berwick DC, Hers I, Heesom KJ, Moule SK, Tavare JM. The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J Biol Chem 2002;277:33895-900
40. Hatzivassiliou G, Zhao F, Bauer DE, Andreadis C, Shaw AN, Dhanak D, Hingorani SR, Tuveson DA, Thompson CB. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005;8:311-21
41. Puri P, Wiest MM, Cheung O, Mirshahi F, Sargeant C, Min HK, Contos MJ, Sterling RK, Fuchs M, Zhou H, Watkins SM, Sanyal AJ. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 2009;50:1827-38
42. Hostetler KY, Zenner BD, Morris HP. Phospholipid content of mitochondrial and microsomal membranes from Morris hepatomas of varying growth rates. Cancer Res 1979;38:2978-83
43. Sun B, Zhang X, Talathi S, Cummings BS. Inhibition of Ca2+independent phospholipase A2 decreases prostate cancer cell growth by p53-dependent and independent mechanisms. J Pharmacol Exp Ther 2008;326:59-68
44. Valianpour F, Wanders RJ, Overmars H, Vaz FM, Barth PG, van Gennip AH. Linoleic acid supplemention of Barth syndrome fibroblasts restores cardiolipin levels: implications for treatment. J Lipid Res 2003;44:560-6
45. Winnik S, Lohmann C, Richter EK, Schäfer N, Song W-L, Leiber F, Mocharla P, Hofmann J, Klingenberg R, Boren J, Becher B, FitzGerald GA, Lüscher TF, Matter CM, Beer JH. Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T-cell-driven inflammation. Eur Heart J 2011;32:2573-84